Homo sapiens Protein: ATP1A3 | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-53556.6 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | ATP1A3 | ||||||||||||||||||||||
Protein Name | ATPase, Na+/K+ transporting, alpha 3 polypeptide | ||||||||||||||||||||||
Synonyms | AHC2; DYT12; RDP; | ||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||
Ensembl Protein | ENSP00000302397 | ||||||||||||||||||||||
InnateDB Gene | IDBG-53554 (ATP1A3) | ||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients. | ||||||||||||||||||||||
Subcellular Localization | Cell membrane {ECO:0000269PubMed:7711835}; Multi-pass membrane protein {ECO:0000269PubMed:7711835}. | ||||||||||||||||||||||
Disease Associations | Dystonia 12 (DYT12) [MIM:128235]: An autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability. {ECO:0000269PubMed:15260953, ECO:0000269PubMed:19351654, ECO:0000269PubMed:19652145}. Note=The disease is caused by mutations affecting the gene represented in this entry.Alternating hemiplegia of childhood 2 (AHC2) [MIM:614820]: A rare syndrome of episodic hemi- or quadriplegia lasting minutes to days. Most cases are accompanied by dystonic posturing, choreoathetoid movements, nystagmus, other ocular motor abnormalities, autonomic disturbances, and progressive cognitive impairment. It is typically distinguished from familial hemiplegic migraine by infantile onset and high prevalence of associated neurological deficits that become increasingly obvious with age. {ECO:0000269PubMed:22842232, ECO:0000269PubMed:22850527, ECO:0000269PubMed:23409136}. Note=The disease is caused by mutations affecting the gene represented in this entry.Note=ATP1A3 mutations are a cause of cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorineural hearing loss syndrome (CAPOS) (PubMed:24468074). Patients present with a relapsing and partially remitting, early-onset cerebellar ataxia following a febrile illness. Other features include progressive optic atrophy and sensorineural hearing loss, generalized hypotonia, areflexia and pes cavus without evidence of a peripheral neuropathy on neurophysiological studies. {ECO:0000269PubMed:24468074}. | ||||||||||||||||||||||
Tissue Specificity | |||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 6 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||
InterPro |
IPR001757
Cation-transporting P-type ATPase IPR004014 Cation-transporting P-type ATPase, N-terminal IPR005775 Sodium/potassium-transporting P-type ATPase, subfamily IIC IPR006068 Cation-transporting P-type ATPase, C-terminal IPR008250 P-type ATPase, A domain IPR023214 HAD-like domain IPR023299 P-type ATPase, cytoplasmic domain N |
||||||||||||||||||||||
PFAM |
PF00690
PF00689 PF00122 PF00702 PF08282 PF13419 |
||||||||||||||||||||||
PRINTS |
PR00119
PR00120 |
||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||
SMART |
SM00831
|
||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | P13637 | ||||||||||||||||||||||
PhosphoSite | PhosphoSite-P13637 | ||||||||||||||||||||||
TrEMBL | Q58I21 | ||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 478 | ||||||||||||||||||||||
UniGene | Hs.709141 | ||||||||||||||||||||||
RefSeq | NP_689509 | ||||||||||||||||||||||
HUGO | HGNC:801 | ||||||||||||||||||||||
OMIM | 182350 | ||||||||||||||||||||||
CCDS | CCDS12594 | ||||||||||||||||||||||
HPRD | 01666 | ||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | AC010616 AK295078 AK296557 AY946015 BC009282 BC009394 BC015566 M27570 M27573 M27577 M28284 M28285 M28286 M28287 M28289 M28290 M28291 M28292 M28293 M35821 M35822 M37436 M37437 M37438 M37439 M37440 M37441 M37442 M37443 M37444 M37445 M37447 M37448 M37449 M37450 M37451 M37452 M37453 M37454 M37455 M37456 M37457 M37462 X12910 X12911 X12912 X12913 X12914 X12915 X12916 X12917 X12919 X12920 X12921 X12922 X12923 | ||||||||||||||||||||||
GenPept | AAA51798 AAA52285 AAA52286 AAA58380 AAH09282 AAH09394 AAH15566 AAX55910 BAH11966 BAH12387 CAA31390 | ||||||||||||||||||||||